Donawa Lifescience Consulting (DLC) participated in the exhibition that formed part of the ICI 2017 Innovations in Cardiovascular Interventions Meeting held from 3-5 December 2017 at the David Intercontinental Convention Center, Tel Aviv, Israel.

The ICI Meeting is the premier International Conference on Innovations in Cardiovascular Interventions (Heart, Brain and Peripheral Vessels) and High-Tech Life Science Industry, aiming to explore, fuel, spark and facilitate innovations that will shape the future of cardiovascular systems. Over the last 2 decades, Israel has turned into a medical start-up nation, and ICI has contributed to this process by facilitating global interaction between physicians, entrepreneurs, academia and industry and building bridges, leading to extensive innovation in the sector.

Representing DLC at the exhibition were Daniela Karrer, Director, Clinical Affairs, Matteo Mosso, Clinical Project Manager, and Silvia Pesci, Clinical Regulatory and QA Specialist. Daniela, Matteo and Slivia were pleased to meet many existing and potential new clients at the DLC booth.

Roger Gray, DLC’s VP Quality and Regulatory, will be speaking on the second day of the seminar on the topic of ‘Synchronizing Reimbursement with Regulatory Strategy’.